News December 7, 2016 - Codman Neuro Announces Acquisition Of Pulsar Vascular Inc., Expanding Neurovascular Treatment For Patients With Complex Aneurysms Read More November 17, 2016 - Diazon Pharmaceutical’s anti-cancer agent DZ-2384 mechanism for high activity and low neurotoxicity published by McGill researchers in Science Translational Medicine Read More November 16, 2016 - Glycomine, Inc. Announces $12 Million Series A Financing to Advance a New Generation of Replacement Therapies for Rare Diseases Read More November 15, 2016 - San Francisco VA, UCSF And CalciMedica, Inc. Present Results On CRAC Channel Inhibitors In Traumatic Brain Injury Model At Neuroscience Meeting Read More November 14, 2016 - CalciMedica Announces Senior Clinical Development Hire Read More November 10, 2016 - DalCor Announces Data to be Presented at the American Heart Association Scientific Sessions 2016 in New Orleans Read More November 4, 2016 - ViaCyte to Present at Healthcare Events in November Read More October 19, 2016 - Lineagen Announces Launch of Proprietary Variant Index to Improve Interpretation of Genetic Basis for Childhood Developmental Delay Read More October 11, 2016 - ViaCyte to Present at Healthcare Events in October Read More October 4, 2016 - Altor BioScience Corporation and NantKwest Inc. Announce Co-Development Agreement to Advance Innovative Natural Killer Cell Combination Immunotherapies for the Treatment of Cancer Read More